Dr. Nahid is Professor in Residence in the Division of Pulmonary and Critical Care Medicine, Director of the UCSF Center for Tuberculosis (https://tb.ucsf.edu), Director of Clinical Trials Operations in the UCSF Office of Research, and Medical Director of the UCSF CTSA Trials Innovation Network Hub. His research includes the conduct of clinical trials and translational research in TB with the goal of improving the care of patients with TB and HIV/TB worldwide. Dr. Nahid leads NIH and CDC-funded field studies of new TB diagnostics, Phase 2 and 3 clinical trials in TB therapeutics and latent TB infection treatment implementation studies in partnership with the Vietnam National TB Program, the Vietnam National Lung Hospital, the Hanoi Lung Hospital, Cho Ray Hospital and the Vietnam National Institute of Hygiene and Epidemiology. Dr. Nahid also oversees NIH and BMGF-funded TB biomarker discovery and qualification programs to identify improved biomarkers of treatment effect. Dr. Nahid serves as Chair of the CDC-TBTC Core Science Group and has led the WHO Task Force for New TB Drugs and Treatment Regimens. He leads and has contributed to the development of U.S. and international practice guidelines for the treatment of TB, and provides clinical TB consultation and trainings as part of the UCSF Curry International TB Center of Excellence.